3 ms·
Development of an ultrahigh affinity, trimeric ACE2 biologic as a universal SARS-CoV-2 antagonist https://www.nature.com/articles/s42003-025-08819-w https://ww
by rolph 1y ago
Development of an ultrahigh affinity, trimeric ACE2 biologic as a universal SARS-CoV-2 antagonist
https://www.nature.com/articles/s42003-025-08819-w https://www.nature.com/articles/s42003-025-08819-w